Principal Financial Group Inc Roivant Sciences Ltd. Transaction History

Principal Financial Group Inc

  • $167 Billion
  • Q1 2025

A detailed history of Principal Financial Group Inc transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Principal Financial Group Inc holds 968,639 shares of ROIV stock, worth $11.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
968,639
Previous 984,519 1.61%
Holding current value
$11.2 Million
Previous $11.6 Million 16.08%
% of portfolio
0.01%
Previous 0.01%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 28, 2025
SELL
$10.09 - $12.08 $160,229 - $191,830
-15,880 Reduced 1.61%
968,639 $9.77 Million
Q4 2024

Jan 31, 2025
BUY
$11.16 - $12.71 $11 Million - $12.5 Million
984,519 New
984,519 $11.6 Million
Q3 2024

Oct 31, 2024
SELL
$10.17 - $12.5 $1.48 Million - $1.82 Million
-145,614 Reduced 12.6%
1,009,758 $11.7 Million
Q2 2024

Jul 29, 2024
SELL
$10.36 - $11.74 $1.24 Million - $1.4 Million
-119,365 Reduced 9.36%
1,155,372 $12.2 Million
Q1 2024

Apr 29, 2024
BUY
$9.87 - $11.8 $12.2 Million - $14.6 Million
1,238,460 Added 3413.9%
1,274,737 $13.4 Million
Q4 2023

Feb 07, 2024
SELL
$8.38 - $11.58 $45,486 - $62,856
-5,428 Reduced 13.02%
36,277 $407,000
Q3 2023

Nov 02, 2023
BUY
$9.76 - $13.19 $127,914 - $172,868
13,106 Added 45.83%
41,705 $487,000
Q2 2023

Aug 07, 2023
BUY
$7.09 - $10.08 $202,766 - $288,277
28,599 New
28,599 $288,000

Others Institutions Holding ROIV

# of Institutions
336
Shares Held
495M
Call Options Held
3.67M
Put Options Held
754K
View Full List

About Roivant Sciences Ltd.

ROIV Quotes by TradingView
  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.14B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email